. . . . . . . "[The oral administration of EPPS substantially reduces hippocampus-dependent behavioural deficits, brain A? oligomer and plaque deposits, glial ?-aminobutyric acid (GABA) release and brain inflammation in an A?-overexpressing, APP/PS1 transgenic mouse model when initiated after the development of severe AD-like phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:38+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .